Monthly newsletter: Read the latest issue
Learn more about our degree programs and admission requirements
Find the information you need to conduct your research and academic studies
See KCUMB's beautiful campus
See faculty research interests
See five-year campus master plan
There are several ongoing clinical trials at KCUMB. To learn more about participating, visit our Volunteer Education Center. If you do not see a study below that interests you, you may still sign up for future studies.
Select a category or scroll down to see all studies now enrolling:
AIDS/HIVAsthmaAllergies, SeasonalCholesterolChronic Back PainChronic BronchitisCOPD
DiabetesEmphysemaFibromyalgiaGastro-esophageal RefluxHigh CholesterolHypertension/High Blood PressureInfectious Disease
InfluenzaIrritable Bowel SyndromePregnancyReactive Airway Disorder
Description: D5896C00027 | A 26 week, randomized, double-blind, parallel-group, active controlled, multicenter, multinational safety study evaluating the risk of serious asthma-related events during treatment with Symbicort®, a fixed combination of inhaled corticosteroid (ICS) (budesonide) and a long acting β2-agonist (LABA) (formoterol) as compared to treatment with ICS (budesonide) alone in adult and adolescent (≥12 years of age) patients with asthma.Contact Information: Center for Community and Clinical Research, email@example.com or 1-877-425-0250.
KCUMB’s Center for Community and Clinical Research is currently recruiting subjects for a 12-month outpatient study of an investigational diabetes medication. Compensation is available for time and travel.
Description: NN1218-3852 | Efficacy and safety of FIAsp compared to insulin aspart both in combination with insulin detemir in adults with Type 1 diabetes. Contact Information: Center for Community and Clinical Research, firstname.lastname@example.org or 1-877-425-0250.
Description: A randomized, double-blind, placebo-controlled, event-driven trial of weekly low-dose methotrexate (LDM) in the prevention of recurrent cardiovascular events among stable post-myocardial infarction patients with type 2 diabetes or metabolic syndrome. Contact Information: Center for Community and Clinical Research, email@example.com or 1-877-425-0250.
1750 Independence AvenueKansas City, Mo. 64106-14531-800-234-4847 | 816-654-7000
If you are experiencing an issue with our website, such as a broken link or incorrect information, please submit the full URL of the page below along with a description of the issue. We also welcome all general feedback about the KCUMB website.
Would you like a member of the web team to follow up with you?